These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11165396)

  • 21. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
    Carmassi F; Morale M; Puccetti R; De Negri F; Monzani F; Navalesi R; Mariani G
    Thromb Res; 1992 Sep; 67(6):643-54. PubMed ID: 1440530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer.
    Shoji M; Hancock WW; Abe K; Micko C; Casper KA; Baine RM; Wilcox JN; Danave I; Dillehay DL; Matthews E; Contrino J; Morrissey JH; Gordon S; Edgington TS; Kudryk B; Kreutzer DL; Rickles FR
    Am J Pathol; 1998 Feb; 152(2):399-411. PubMed ID: 9466566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of platelet-derived β-thromboglobulins on coagulation.
    Egan K; van Geffen JP; Ma H; Kevane B; Lennon A; Allen S; Neary E; Parsons M; Maguire P; Wynne K; O' Kennedy R; Heemskerk JWM; Áinle FN
    Thromb Res; 2017 Jun; 154():7-15. PubMed ID: 28384443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
    Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
    Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor VIIa and tissue factor.
    Carson SD
    FEBS Lett; 1981 Sep; 132(1):37-40. PubMed ID: 6795061
    [No Abstract]   [Full Text] [Related]  

  • 26. Positive feedback loops for factor V and factor VII activation supply sensitivity to local surface tissue factor density during blood coagulation.
    Balandina AN; Shibeko AM; Kireev DA; Novikova AA; Shmirev II; Panteleev MA; Ataullakhanov FI
    Biophys J; 2011 Oct; 101(8):1816-24. PubMed ID: 22004734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic peptide analogs of tissue factor and factor VII which inhibit factor Xa formation by the tissue factor/factor VIIa complex.
    Rønning HF; Risøen UC; Orning L; Sletten K; Sakariassen KS
    Thromb Res; 1996 Oct; 84(2):73-81. PubMed ID: 8897697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative pathways of thromboplastin-dependent activation of human factor X in plasma.
    Marlar RA; Griffin JH
    Ann N Y Acad Sci; 1981; 370():325-35. PubMed ID: 6943963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in vitro analysis of the coagulation mechanism of activated factor VII using thrombelastogram.
    Kawaguchi C; Takahashi Y; Hanesaka Y; Yoshioka A
    Thromb Haemost; 2002 Nov; 88(5):768-72. PubMed ID: 12428092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa.
    Ollivier V; Chabbat J; Herbert JM; Hakim J; de Prost D
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1374-81. PubMed ID: 10807756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of bovine factor IX by the reaction product of bovine factor VII and human tissue factor.
    Liu DY; Rosen S
    Chin Med J (Engl); 1994 Mar; 107(3):181-5. PubMed ID: 8088177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of factor IX in tissue thromboplastin induced coagulation.
    van den Besselaar AM; Ram IE; Alderkamp GH; Bertina RM
    Thromb Haemost; 1982 Aug; 48(1):54-8. PubMed ID: 6982540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No effect of factor Xa or tissue thromboplastin and factor VII on the activation of plasminogen.
    Wiman B; Holm T; Prydz H
    Thromb Res; 1976 Nov; 9(5):523-5. PubMed ID: 136768
    [No Abstract]   [Full Text] [Related]  

  • 35. Elevated coagulation factor levels affect the tissue factor-threshold in thrombin generation.
    Rietveld IM; Schreuder M; Reitsma PH; Bos MHA
    Thromb Res; 2018 Dec; 172():104-109. PubMed ID: 30408635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of an acidic environment on coagulation dynamics.
    Gissel M; Brummel-Ziedins KE; Butenas S; Pusateri AE; Mann KG; Orfeo T
    J Thromb Haemost; 2016 Oct; 14(10):2001-2010. PubMed ID: 27431334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade by ruthenium red of tissue factor-initiated coagulation.
    Chu AJ; Wang ZG; Nwobi OI; Beydoun S
    Br J Pharmacol; 2001 Jul; 133(5):659-64. PubMed ID: 11429389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the mechanism of inhibition of tissue factor pathway by the synthetic pentasaccharide during coagulation of human plasma.
    Gerotziafas GT; Elalamy I; Depasse F; Chakroun T; Bara L; Arzoglou P; Samama MM
    Blood Coagul Fibrinolysis; 2003 Oct; 14(7):633-8. PubMed ID: 14517487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of activated coagulation factor VII by normal human plasma.
    Dahl PE; Abildgaard U; Larsen ML; Tjensvoll L
    Thromb Haemost; 1982 Dec; 48(3):253-6. PubMed ID: 7164015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombin generation measurement in factor VII-depleted plasmas compared to inherited factor VII-deficient plasmas.
    Giansily-Blaizot M; Al Dieri R; Schved JF
    Pathophysiol Haemost Thromb; 2003; 33(1):36-42. PubMed ID: 12853711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.